3 research outputs found
Additional file 1: Table S1. of Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study
Drug acquisition cost considered in the model. (DOCX 79 kb
MOESM3 of Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
Additional file 3: Table S2. Area under curve (AUC) for predicting 90-day mortality of bioactive adrenomedullin (bio-ADM), lactate, mean arterial pressure (MAP), heart rate (HR), cardiac index (CI), and central venous pressure (CVP) measured at 48–96 h of the detection of cardiogenic shock
MOESM2 of Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
Additional file 2: Table S1. Causes of death as reported by local investigators in patients who died early (within 48 h from the detection of shock) and late (more than 48 h from the detection of shock)